{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:06:43Z","timestamp":1794344803672,"version":"4.9.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["AR51749"],"award-info":[{"award-number":["AR51749"]}]},{"name":"National Institute of Health United states","award":["AR51749"],"award-info":[{"award-number":["AR51749"]}]},{"name":"National Institute of Health United states","award":["AR51749"],"award-info":[{"award-number":["AR51749"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03589-1","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:02:15Z","timestamp":1749038535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of human factor H-related gene and protein expressed in rheumatoid arthritis synovium identifies a novel mechanism promoting dysregulated complement pathway activation"],"prefix":"10.1038","volume":"15","author":[{"given":"Nirmal K.","family":"Banda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry W.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Deane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Simberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I.","family":"Scheinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Accelerating Medicines Partnership (AMP) RA\/SLE Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Anolik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Tabechian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hossler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Meednu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rangel-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ritchlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Bykerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Donlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"DiCarlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Orange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Carrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nwawka Endo","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Satija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Ivashkiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pernis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Darnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Figgie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael McNamara. Mandy J.","family":"McGeachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Kolls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Cordle, Peter Gregersen Dian","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Filer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Turner Holly","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Kelly Rebecca","family":"Hands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Michael","family":"Holers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Deane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal K.","family":"Banda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry W.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Merkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Firestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Ben-Artzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsy","family":"Forbess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Gravallese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Salomon-Escoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harris","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Mandelin Emily","family":"Bacalao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Bathon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Pitzalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Michael","family":"Holers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"3589_CR1","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross, M. et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann. Rheumatol. Dis. 73, 1316\u20131322 (2014).","journal-title":"Ann. Rheumatol. Dis."},{"key":"3589_CR2","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Primers. 4, 18001 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"3589_CR3","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.15585\/mmwr.mm7241a1","volume":"72","author":"EA Fallon","year":"2023","unstructured":"Fallon, E. A. et al. Prevalence of diagnosed Arthritis - United States, 2019\u20132021. MMWR Morb Mortal. Wkly. Rep. 72, 1101\u20131107 (2023).","journal-title":"MMWR Morb Mortal. Wkly. Rep."},{"key":"3589_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.14423\/SMJ.0000000000001026","volume":"112","author":"DK Singh","year":"2019","unstructured":"Singh, D. K. et al. Use of rheumatologic testing in patients who eventually receive a diagnosis of rheumatoid arthritis. South Med. J. 112, 535\u2013538 (2019).","journal-title":"South Med. J."},{"key":"3589_CR5","doi-asserted-by":"crossref","unstructured":"Prevoo, M. L., van \u2018t Hof, M. A., Kuper, H. H., van Leeuwen, M. A. & van de Putte, L. B. and P. L. van Riel. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheumatol 38: 44\u201348. (1995).","DOI":"10.1002\/art.1780380107"},{"key":"3589_CR6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/1756-185X.12695","volume":"18","author":"I Sengul","year":"2015","unstructured":"Sengul, I., Akcay-Yalbuzdag, S., Ince, B., Goksel-Karatepe, A. & Kaya, T. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis. Int. J. Rheumatol. Dis. 18, 640\u2013645 (2015).","journal-title":"Int. J. Rheumatol. Dis."},{"key":"3589_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen, M. M. et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheumatol. 50, 380\u2013386 (2004).","journal-title":"Arthritis Rheumatol."},{"key":"3589_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","volume":"56","author":"E Ballanti","year":"2013","unstructured":"Ballanti, E. et al. Complement and autoimmunity. Immunol. Res. 56, 477\u2013491 (2013).","journal-title":"Immunol. Res."},{"key":"3589_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3389\/fimmu.2018.01057","volume":"9","author":"VM Holers","year":"2018","unstructured":"Holers, V. M. & Banda, N. K. Complement in the initiation and evolution of rheumatoid arthritis. Front. Immunol. 9, 1057 (2018).","journal-title":"Front. Immunol."},{"key":"3589_CR10","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.4049\/jimmunol.2101170","volume":"208","author":"NK Banda","year":"2022","unstructured":"Banda, N. K. et al. Analysis of complement gene expression, clinical associations, and biodistribution of complement proteins in the synovium of early rheumatoid arthritis patients reveals unique pathophysiologic features. J. Immunol. 208, 2482\u20132496 (2022).","journal-title":"J. Immunol."},{"key":"3589_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","volume":"171","author":"MM Markiewski","year":"2007","unstructured":"Markiewski, M. M. & Lambris, J. D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171, 715\u2013727 (2007).","journal-title":"Am. J. Pathol."},{"key":"3589_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V. & Roumenina, L. T. Complement system part II: role in immunity. Front. Immunol. 6, 257 (2015).","journal-title":"Front. Immunol."},{"key":"3589_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.imlet.2004.11.010","volume":"97","author":"BP Morgan","year":"2005","unstructured":"Morgan, B. P., Marchbank, K. J., Longhi, M. P., Harris, C. L. & Gallimore, A. M. Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett. 97, 171\u2013179 (2005).","journal-title":"Immunol. Lett."},{"key":"3589_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.semcdb.2017.06.009","volume":"72","author":"BP Morgan","year":"2017","unstructured":"Morgan, B. P., Boyd, C. & Bubeck, D. Molecular cell biology of complement membrane attack. Semin Cell. Dev. Biol. 72, 124\u2013132 (2017).","journal-title":"Semin Cell. Dev. Biol."},{"key":"3589_CR15","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3389\/fimmu.2018.01691","volume":"9","author":"SA Zwarthoff","year":"2018","unstructured":"Zwarthoff, S. A. et al. Functional characterization of alternative and classical pathway C3\/C5 convertase activity and Inhibition using purified models. Front. Immunol. 9, 1691 (2018).","journal-title":"Front. Immunol."},{"key":"3589_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/jth.12837","volume":"13","author":"JH Foley","year":"2015","unstructured":"Foley, J. H. et al. Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses. J. Thromb. Haemost. 13, 610\u2013618 (2015).","journal-title":"J. Thromb. Haemost"},{"key":"3589_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3109\/03009734.2010.528465","volume":"116","author":"UR Nilsson","year":"2011","unstructured":"Nilsson, U. R., Funke, L., Nilsson, B. & Ekdahl, K. N. Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies. Ups J. Med. Sci. 116, 26\u201333 (2011).","journal-title":"Ups J. Med. Sci."},{"key":"3589_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.it.2008.04.008","volume":"29","author":"M Jozsi","year":"2008","unstructured":"Jozsi, M. & Zipfel, P. F. Factor H family proteins and human diseases. Trends Immunol. 29, 380\u2013387 (2008).","journal-title":"Trends Immunol."},{"key":"3589_CR19","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1042\/bst0300971","volume":"30","author":"PF Zipfel","year":"2002","unstructured":"Zipfel, P. F. et al. Factor H family proteins: on complement, microbes and human diseases. Biochem. Soc. Trans. 30, 971\u2013978 (2002).","journal-title":"Biochem. Soc. Trans."},{"key":"3589_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0167-5699(94)90155-4","volume":"15","author":"PF Zipfel","year":"1994","unstructured":"Zipfel, P. F. & Skerka, C. Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunol. Today. 15, 121\u2013126 (1994).","journal-title":"Immunol. Today"},{"key":"3589_CR21","doi-asserted-by":"publisher","first-page":"660852","DOI":"10.3389\/fimmu.2021.660852","volume":"12","author":"E Karpati","year":"2021","unstructured":"Karpati, E. et al. Complement factor H family proteins modulate monocyte and neutrophil granulocyte functions. Front. Immunol. 12, 660852 (2021).","journal-title":"Front. Immunol."},{"key":"3589_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3389\/fimmu.2020.01297","volume":"11","author":"E Karpati","year":"2020","unstructured":"Karpati, E. et al. Interaction of the factor H family proteins FHR-1 and FHR-5 with DNA and dead cells: implications for the regulation of complement activation and opsonization. Front. Immunol. 11, 1297 (2020).","journal-title":"Front. Immunol."},{"key":"3589_CR23","doi-asserted-by":"publisher","first-page":"1135490","DOI":"10.3389\/fimmu.2024.1135490","volume":"15","author":"N Sandor","year":"2024","unstructured":"Sandor, N. et al. The human factor H protein family\u2014an update. Front. Immunol. 15, 1135490 (2024).","journal-title":"Front. Immunol."},{"key":"3589_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.molimm.2014.06.028","volume":"62","author":"G Mehta","year":"2014","unstructured":"Mehta, G., Ferreira, V. P., Skerka, C., Zipfel, P. F. & Banda, N. K. New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases. Mol. Immunol. 62, 235\u2013248 (2014).","journal-title":"Mol. Immunol."},{"key":"3589_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","volume":"242","author":"JV Castell","year":"1989","unstructured":"Castell, J. V. et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 242, 237\u2013239 (1989).","journal-title":"FEBS Lett."},{"key":"3589_CR26","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston, N. R. & Ashworth, J. J. Role of C-reactive protein at sites of inflammation and infection. Front. Immunol. 9, 754 (2018).","journal-title":"Front. Immunol."},{"key":"3589_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.semarthrit.2020.11.005","volume":"51","author":"JE Pope","year":"2021","unstructured":"Pope, J. E. & Choy, E. H. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheumatol. 51, 219\u2013229 (2021).","journal-title":"Semin Arthritis Rheumatol."},{"key":"3589_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fmed.2018.00185","volume":"5","author":"CK Orr","year":"2018","unstructured":"Orr, C. K. et al. The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis. Front. Med. (Lausanne). 5, 185 (2018).","journal-title":"Front. Med. (Lausanne)"},{"key":"3589_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molimm.2008.10.029","volume":"46","author":"M Mihlan","year":"2009","unstructured":"Mihlan, M. et al. Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells. Mol. Immunol. 46, 335\u2013344 (2009).","journal-title":"Mol. Immunol."},{"key":"3589_CR30","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.molimm.2009.12.005","volume":"47","author":"M Hebecker","year":"2010","unstructured":"Hebecker, M. et al. Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4. Mol. Immunol. 47, 1347\u20131355 (2010).","journal-title":"Mol. Immunol."},{"key":"3589_CR31","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.4049\/jimmunol.174.10.6250","volume":"174","author":"JL McRae","year":"2005","unstructured":"McRae, J. L. et al. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J. Immunol. 174, 6250\u20136256 (2005).","journal-title":"J. Immunol."},{"key":"3589_CR32","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","volume":"28","author":"MJ Lewis","year":"2019","unstructured":"Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell. Rep. 28, 2455\u20132470e2455 (2019).","journal-title":"Cell. Rep."},{"key":"3589_CR33","doi-asserted-by":"publisher","first-page":"e648","DOI":"10.1016\/S2665-9913(23)00241-2","volume":"5","author":"F Rivellese","year":"2023","unstructured":"Rivellese, F. et al. Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials. Lancet Rheumatol. 5, e648\u2013e659 (2023).","journal-title":"Lancet Rheumatol."},{"key":"3589_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"3589_CR35","doi-asserted-by":"publisher","first-page":"1146563","DOI":"10.3389\/fimmu.2023.1146563","volume":"14","author":"VM Holers","year":"2023","unstructured":"Holers, V. M. et al. Potential causal role of synovial complement system activation in the development of post-traumatic osteoarthritis after anterior cruciate ligament injury or meniscus tear. Front. Immunol. 14, 1146563 (2023).","journal-title":"Front. Immunol."},{"key":"3589_CR36","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.4110\/in.2024.24.e17","volume":"24","author":"VM Holers","year":"2024","unstructured":"Holers, V. M. et al. Decay-accelerating factor differentially associates with complement-mediated damage in synovium after meniscus tear as compared to anterior cruciate ligament injury. Immune Netw. 24, e17 (2024).","journal-title":"Immune Netw."},{"key":"3589_CR37","first-page":"261","volume":"27","author":"D van der Heijde","year":"2000","unstructured":"van der Heijde, D. How to read radiographs according to the Sharp\/van der Heijde method. J. Rheumatol. 27, 261\u2013263 (2000).","journal-title":"J. Rheumatol."},{"key":"3589_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/1529-0131(199809)41:9<1583::AID-ART8>3.0.CO;2-H","volume":"41","author":"HK Genant","year":"1998","unstructured":"Genant, H. K. et al. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheumatol. 41, 1583\u20131590 (1998).","journal-title":"Arthritis Rheumatol."},{"key":"3589_CR39","doi-asserted-by":"publisher","first-page":"152329","DOI":"10.1016\/j.semarthrit.2023.152329","volume":"64S","author":"MJ Lewis","year":"2024","unstructured":"Lewis, M. J. Predicting best treatment in rheumatoid arthritis. Semin Arthritis Rheumatol. 64S, 152329 (2024).","journal-title":"Semin Arthritis Rheumatol."},{"key":"3589_CR40","unstructured":"Humby, F. et al. and R. R. c. Group. 2021. Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet 397: 305\u2013317 ."},{"key":"3589_CR41","doi-asserted-by":"crossref","unstructured":"Donlin, L. T. et al. Methods for high-dimensional analysis of cells dissociated from cryopreserved synovial tissue. Arthritis Res. Ther. 20: 139. (2018).","DOI":"10.1186\/s13075-018-1631-y"},{"key":"3589_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cellimm.2018.03.014","volume":"333","author":"MB Jones","year":"2018","unstructured":"Jones, M. B. IgG and leukocytes: targets of Immunomodulatory alpha2,6 Sialic acids. Cell. Immunol. 333, 58\u201364 (2018).","journal-title":"Cell. Immunol."},{"key":"3589_CR43","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/s41467-021-22365-z","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Loss of alpha2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis. Nat. Commun. 12, 2343 (2021).","journal-title":"Nat. Commun."},{"key":"3589_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41584-022-00867-4","volume":"19","author":"T Kissel","year":"2023","unstructured":"Kissel, T., Toes, R. E. M., Huizinga, T. W. J. & Wuhrer, M. Glycobiology of rheumatic diseases. Nat. Rev. Rheumatol. 19, 28\u201343 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"3589_CR45","doi-asserted-by":"publisher","first-page":"e78617","DOI":"10.1371\/journal.pone.0078617","volume":"8","author":"HU Eberhardt","year":"2013","unstructured":"Eberhardt, H. U. et al. Human factor H-related protein 2 (CFHR2) regulates complement activation. PLoS One. 8, e78617 (2013).","journal-title":"PLoS One"},{"key":"3589_CR46","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood.2020010069","volume":"137","author":"M Merinero","year":"2021","unstructured":"Merinero, M. et al. Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases. Blood 137, 3484\u20133494 (2021).","journal-title":"Blood"},{"key":"3589_CR47","doi-asserted-by":"publisher","first-page":"101341","DOI":"10.1016\/j.smim.2019.101341","volume":"45","author":"M Cserhalmi","year":"2019","unstructured":"Cserhalmi, M., Papp, A., Brandus, B., Uzonyi, B. & Jozsi, M. Regulation of regulators: role of the complement factor H-related proteins. Semin Immunol. 45, 101341 (2019).","journal-title":"Semin Immunol."},{"key":"3589_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/imr.12477","volume":"274","author":"N Medjeral-Thomas","year":"2016","unstructured":"Medjeral-Thomas, N. & Pickering, M. C. The complement factor H-related proteins. Immunol. Rev. 274, 191\u2013201 (2016).","journal-title":"Immunol. Rev."},{"key":"3589_CR49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","volume":"56","author":"C Skerka","year":"2013","unstructured":"Skerka, C., Chen, Q., Fremeaux-Bacchi, V. & Roumenina, L. T. Complement factor H related proteins (CFHRs). Mol. Immunol. 56, 170\u2013180 (2013).","journal-title":"Mol. Immunol."},{"key":"3589_CR50","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1074\/jbc.M109.045427","volume":"285","author":"J Leffler","year":"2010","unstructured":"Leffler, J. et al. Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells. J. Biol. Chem. 285, 3766\u20133776 (2010).","journal-title":"J. Biol. Chem."},{"key":"3589_CR51","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.matbio.2016.09.002","volume":"57\u201358","author":"DB Borza","year":"2017","unstructured":"Borza, D. B. Glomerular basement membrane Heparan sulfate in health and disease: a regulator of local complement activation. Matrix Biol. 57\u201358, 299\u2013310 (2017).","journal-title":"Matrix Biol."},{"key":"3589_CR52","doi-asserted-by":"publisher","first-page":"534","DOI":"10.4049\/jimmunol.2000072","volume":"207","author":"F Gyapon-Quast","year":"2021","unstructured":"Gyapon-Quast, F. et al. Defining the glycosaminoglycan interactions of complement factor H-related protein 5. J. Immunol. 207, 534\u2013541 (2021).","journal-title":"J. Immunol."},{"key":"3589_CR53","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.kint.2021.05.033","volume":"100","author":"S Mahajan","year":"2021","unstructured":"Mahajan, S. et al. Local complement factor H protects kidney endothelial cell structure and function. Kidney Int. 100, 824\u2013836 (2021).","journal-title":"Kidney Int."},{"key":"3589_CR54","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s12967-023-04730-2","volume":"21","author":"Y Jia","year":"2023","unstructured":"Jia, Y. et al. Complement factor H attenuates TNF-alpha-induced inflammation by upregulating EIF3C in rheumatoid arthritis. J. Transl Med. 21, 846 (2023).","journal-title":"J. Transl Med."},{"key":"3589_CR55","doi-asserted-by":"publisher","unstructured":"Jiang Li, K. W. et al. Hoh and. Complement factor H in molecular regulation of angiogenesis. Med. Rev. 4, 452\u2013466. https:\/\/doi.org\/10.1515\/mr-2023-0048 (2024).","DOI":"10.1515\/mr-2023-0048"},{"issue":"12","key":"3589_CR56","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.7150\/jca.19452","volume":"8","author":"Ju","year":"2017","unstructured":"Ju, Liu & Hoh, J. Loss of complement factor H in plasma increases endothelial cell migration. J. Cancer. 8 (12), 2184\u20132190 (2017).","journal-title":"J. Cancer"},{"key":"3589_CR57","unstructured":"Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623: 616\u2013624. (2023)."},{"key":"3589_CR58","doi-asserted-by":"publisher","first-page":"22889","DOI":"10.1038\/srep22889","volume":"6","author":"B Molins","year":"2016","unstructured":"Molins, B. et al. Complement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired with at risk polymorphic CFH variants. Sci. Rep. 6, 22889 (2016).","journal-title":"Sci. Rep."},{"key":"3589_CR59","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.nut.2005.12.004","volume":"22","author":"JM Seddon","year":"2006","unstructured":"Seddon, J. M., Gensler, G., Klein, M. L. & Milton, R. C. C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition 22, 441\u2013443 (2006).","journal-title":"Nutrition"},{"key":"3589_CR60","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/archopht.123.6.774","volume":"123","author":"JM Seddon","year":"2005","unstructured":"Seddon, J. M., George, S., Rosner, B. & Rifai, N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, Interleukin 6, and other cardiovascular biomarkers. Arch. Ophthalmol. 123, 774\u2013782 (2005).","journal-title":"Arch. Ophthalmol."},{"key":"3589_CR61","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.ophtha.2005.07.004","volume":"112","author":"AK Vine","year":"2005","unstructured":"Vine, A. K., Stader, J., Branham, K., Musch, D. C. & Swaroop, A. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 112, 2076\u20132080 (2005).","journal-title":"Ophthalmology"},{"key":"3589_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12014-020-09281-y","volume":"17","author":"JH Lee","year":"2020","unstructured":"Lee, J. H. et al. Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis. Clin. Proteom. 17, 20 (2020).","journal-title":"Clin. Proteom."},{"key":"3589_CR63","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00109-024-02428-6","volume":"102","author":"JH Lee","year":"2024","unstructured":"Lee, J. H. et al. The complement factor H-related protein-5 (CFHR5) exacerbates pathological bone formation in ankylosing spondylitis. J. Mol. Med. (Berl). 102, 571\u2013583 (2024).","journal-title":"J. Mol. Med. (Berl)"},{"key":"3589_CR64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/oxfordjournals.aje.a112878","volume":"111","author":"A Linos","year":"1980","unstructured":"Linos, A., Worthington, J. W., O\u2019Fallon, W. M. & Kurland, L. T. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am. J. Epidemiol. 111, 87\u201398 (1980).","journal-title":"Am. J. Epidemiol."},{"key":"3589_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/ard.59.2.149","volume":"59","author":"HD Halldorsdottir","year":"2000","unstructured":"Halldorsdottir, H. D., Jonsson, T., Thorsteinsson, J. & Valdimarsson, H. A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor. Ann. Rheumatol. Dis. 59, 149\u2013151 (2000).","journal-title":"Ann. Rheumatol. Dis."},{"key":"3589_CR66","doi-asserted-by":"publisher","first-page":"e5244","DOI":"10.1136\/bmj.e5244","volume":"345","author":"SF Nielsen","year":"2012","unstructured":"Nielsen, S. F., Bojesen, S. E., Schnohr, P. & Nordestgaard, B. G. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ 345, e5244 (2012).","journal-title":"BMJ"},{"key":"3589_CR67","first-page":"e15063","volume":"13","author":"SC Shapiro","year":"2021","unstructured":"Shapiro, S. C. Biomarkers in rheumatoid arthritis. Cureus 13, e15063 (2021).","journal-title":"Cureus"},{"key":"3589_CR68","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5114\/ceji.2017.72807","volume":"42","author":"W Kurowska","year":"2017","unstructured":"Kurowska, W., Kuca-Warnawin, E. H., Radzikowska, A. & Maslinski, W. The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Cent. Eur. J. Immunol. 42, 390\u2013398 (2017).","journal-title":"Cent. Eur. J. Immunol."},{"key":"3589_CR69","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4049\/jimmunol.1600053","volume":"197","author":"D Buhlmann","year":"2016","unstructured":"Buhlmann, D. et al. FHR3 blocks C3d-Mediated coactivation of human B cells. J. Immunol. 197, 620\u2013629 (2016).","journal-title":"J. Immunol."},{"key":"3589_CR70","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2249.2003.02173.x","volume":"132","author":"MA Friese","year":"2003","unstructured":"Friese, M. A. et al. Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rheumatoid arthritis. Clin. Exp. Immunol. 132, 485\u2013495 (2003).","journal-title":"Clin. Exp. Immunol."},{"key":"3589_CR71","doi-asserted-by":"crossref","unstructured":"Luce Perie, S. et al. Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology Front. Hematol. 3. (2024).","DOI":"10.3389\/frhem.2024.1469176"},{"key":"3589_CR72","doi-asserted-by":"publisher","first-page":"615748","DOI":"10.3389\/fimmu.2021.615748","volume":"12","author":"A Dopler","year":"2021","unstructured":"Dopler, A. et al. Deregulation of factor H by factor H-related protein 1 depends on sialylation of host surfaces. Front. Immunol. 12, 615748 (2021).","journal-title":"Front. Immunol."},{"key":"3589_CR73","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1002\/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V","volume":"43","author":"PP Tak","year":"2000","unstructured":"Tak, P. P. & Bresnihan, B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheumatol. 43, 2619\u20132633 (2000).","journal-title":"Arthritis Rheumatol."},{"key":"3589_CR74","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein, G. S. Evolving concepts of rheumatoid arthritis. Nature 423, 356\u2013361 (2003).","journal-title":"Nature"},{"key":"3589_CR75","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1093\/hmg\/ddq399","volume":"19","author":"LG Fritsche","year":"2010","unstructured":"Fritsche, L. G. et al. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum. Mol. Genet. 19, 4694\u20134704 (2010).","journal-title":"Hum. Mol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03589-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03589-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03589-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T13:03:49Z","timestamp":1749042229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03589-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3589"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03589-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. NKB: royalties, and patents for the treatment of inflammatory diseases using anti-C5aR1ab-C5siRNA conjugate. LWM: none; KDD: none; DS, none; RIS: none; RMF: none; JS, none; RL: none; CP: none; MJL: none; VMH: royalties, consulting income, stock, and stock options in complement therapeutics companies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written ethical informed consent was obtained from all eRA patients according to the preapproved Colorado Multiple Institutional Review Board protocol (COMIRB # 20-1908 and 15-1389). All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols related to these studies were approved by the Institutional Review Board committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"19633"}}